CD8A and neoplasm: Re-activating the immune system typically requires exogenous antigen-presenting cells (APCs), which present tumor-associated antigens to cytotoxic (CD8+) and helper (CD4+) T cells via major histocompatibility complex (MHC) molecules [2].